SG Americas Securities’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-85,163
| Closed | -$440K | – | 2928 |
|
|
2021
Q3 | $440K | Sell |
85,163
-150,551
| -64% | -$778K | ﹤0.01% | 2412 |
|
|
2021
Q2 | $1M | Buy |
235,714
+814
| +0.3% | +$3.47K | ﹤0.01% | 1411 |
|
|
2021
Q1 | $1.25M | Buy |
+234,900
| New | +$1.25M | 0.01% | 1236 |
|
|
2019
Q4 | – | Sell |
-21,987
| Closed | -$33K | – | 2664 |
|
|
2019
Q3 | $33K | Sell |
21,987
-1,272
| -5% | -$1.91K | ﹤0.01% | 2405 |
|
|
2019
Q2 | $94K | Buy |
23,259
+4,752
| +26% | +$19.2K | ﹤0.01% | 2424 |
|
|
2019
Q1 | $80K | Sell |
18,507
-1,497
| -7% | -$6.47K | ﹤0.01% | 2705 |
|
|
2018
Q4 | $115K | Buy |
20,004
+12,229
| +157% | +$70.3K | ﹤0.01% | 2257 |
|
|
2018
Q3 | $105K | Sell |
7,775
-13,123
| -63% | -$177K | ﹤0.01% | 2475 |
|
|
2018
Q2 | $248K | Sell |
20,898
-396
| -2% | -$4.7K | ﹤0.01% | 2158 |
|
|
2018
Q1 | $239K | Buy |
+21,294
| New | +$239K | ﹤0.01% | 1965 |
|